Stocktitan
Published September 14, 2026 · Updated September 15, 2026
Rhelion Filament to Deliver Oral Comments at FDA Hearing | TRUFF Stock News
Read the full story at Stocktitan
PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE... ... Psychedelic Drugs. Rhelion's subsidiary Filament will speak at an FDA.
Surfaced by this Google Alert
- Psychedelic biotech
